These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8974615)

  • 1. [Can the type of GnRH used during long in vitro fertilization protocols influence the pregnancy rate?].
    Librati C; Hocke C; Filet JP; Papaxanthos A; Mene D; Dulucq MC; Leng JJ
    Contracept Fertil Sex; 1996 Oct; 24(10):762-6. PubMed ID: 8974615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of ovulation induction protocols after endometrioma resection.
    Bastu E; Yasa C; Dural O; Mutlu MF; Celik C; Ugurlucan FG; Buyru F
    JSLS; 2014; 18(3):. PubMed ID: 25392665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of 3 long ovarian stimulation protocols for in vitro fertilization using a delayed acting GnRH analogue].
    Vauthier-Brouzes D; Lefebvre G
    Contracept Fertil Sex; 1993 Mar; 21(3):209-12. PubMed ID: 7951614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the preferred GnRH analogue for polycystic ovary syndrome patients undergoing controlled ovarian hyperstimulation for in vitro fertilization?
    Orvieto R; Meltcer S; Homburg R; Nahum R; Rabinson J; Ashkenazi J
    Fertil Steril; 2009 Apr; 91(4 Suppl):1466-8. PubMed ID: 18774558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of adenomyosis on IVF after long or ultra-long GnRH agonist treatment.
    Hou X; Xing J; Shan H; Mei J; Sun Y; Yan G; Sun H; Wang J
    Reprod Biomed Online; 2020 Nov; 41(5):845-853. PubMed ID: 32972873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian stimulation in in vitro fertilization with or without the "long" gonadotropin-releasing hormone agonist protocol: effect on cycle duration and outcome.
    Beloosesky R; Kol S; Lightman A; Itskovitz-Eldor J
    Fertil Steril; 2000 Jul; 74(1):166-8. PubMed ID: 10899516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovulation induction and luteal support with GnRH agonist in patients at high risk for hyperstimulation syndrome.
    Fusi FM; Arnoldi M; Bosisio C; Lombardo G; Ferrario M; Zanga L; Galimberti A; Capitanio E
    Gynecol Endocrinol; 2015; 31(9):693-7. PubMed ID: 26527503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ovarian stimulation using a protocol of low dose agonist in patients with an elevated basal FSH].
    Olivennes F; Righini C; Fanchin R; Torrisi C; Hazout A; Glissant M; Fernandez H; Frydman R
    Contracept Fertil Sex; 1996 Dec; 24(12):912-6. PubMed ID: 9026280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GnRH-agonist ovulation trigger in patients undergoing controlled ovarian hyperstimulation for IVF with ultrashort flare GnRH-agonist combined with multidose GnRH-antagonist protocol.
    Orvieto R; Nahum R; Zohav E; Liberty G; Anteby EY; Meltcer S
    Gynecol Endocrinol; 2013 Jan; 29(1):51-3. PubMed ID: 22857268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of leuprolide acetate and triptorelin in assisted reproductive technology cycles: a prospective, randomized study.
    Orvieto R; Kerner R; Krissi H; Ashkenazi J; Ben Rafael Z; Bar-Hava I
    Fertil Steril; 2002 Dec; 78(6):1268-71. PubMed ID: 12477523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which luteal phase support is better for each IVF stimulation protocol to achieve the highest pregnancy rate? A superiority randomized clinical trial.
    Gizzo S; Andrisani A; Esposito F; Noventa M; Di Gangi S; Angioni S; Litta P; Gangemi M; Nardelli GB
    Gynecol Endocrinol; 2014; 30(12):902-8. PubMed ID: 25268567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrashort flare GnRH agonist combined with flexible multidose GnRH antagonist for patients with repeated IVF failures and poor embryo quality.
    Orvieto R; Nahum R; Rabinson J; Gemer O; Anteby EY; Meltcer S
    Fertil Steril; 2009 Apr; 91(4 Suppl):1398-400. PubMed ID: 18675974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ovarian stimulation for in vitro fertilization using LHRH agonists: comparison of plasma and intra-follicular hormone profiles using "short" and "long" protocols].
    Antoine JM; Firmin C; Alvarez S; Cornet D; Tibi C; Mandelbaum J; Plachot M; Salat-Baroux J
    J Gynecol Obstet Biol Reprod (Paris); 1990; 19(8):1035-40. PubMed ID: 2150525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study.
    Engmann L; DiLuigi A; Schmidt D; Nulsen J; Maier D; Benadiva C
    Fertil Steril; 2008 Jan; 89(1):84-91. PubMed ID: 17462639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GnRH agonist and antagonist protocols for stage I-II endometriosis and endometrioma in in vitro fertilization/intracytoplasmic sperm injection cycles.
    Pabuccu R; Onalan G; Kaya C
    Fertil Steril; 2007 Oct; 88(4):832-9. PubMed ID: 17428479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dynamics of endometrial growth and the triple layer appearance in three different controlled ovarian hyperstimulation protocols and their influence on IVF outcomes.
    Kuć P; Kuczyńska A; Topczewska M; Tadejko P; Kuczyński W
    Gynecol Endocrinol; 2011 Nov; 27(11):867-73. PubMed ID: 21231852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revisiting gonadotrophin-releasing hormone agonist protocols and management of poor ovarian responses to gonadotrophins.
    Hugues JN; Cédrin Durnerin IC
    Hum Reprod Update; 1998; 4(1):83-101. PubMed ID: 9622415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GnRH antagonist versus long GnRH agonist protocol in poor IVF responders: a randomized clinical trial.
    Prapas Y; Petousis S; Dagklis T; Panagiotidis Y; Papatheodorou A; Assunta I; Prapas N
    Eur J Obstet Gynecol Reprod Biol; 2013 Jan; 166(1):43-6. PubMed ID: 23020996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone-gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Fatemi HM; Polyzos NP; van Vaerenbergh I; Bourgain C; Blockeel C; Alsbjerg B; Papanikolaou EG; Humaidan P
    Fertil Steril; 2013 Sep; 100(3):742-7. PubMed ID: 23806846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does prolonged pituitary down-regulation with gonadotropin-releasing hormone agonist improve the live-birth rate in in vitro fertilization treatment?
    Ren J; Sha A; Han D; Li P; Geng J; Ma C
    Fertil Steril; 2014 Jul; 102(1):75-81. PubMed ID: 24746740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.